Mitigation of disease- and treatment-related risks in patients with psoriatic arthritis

Overview of attention for article published in Arthritis Research & Therapy, March 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

policy: 1 policy source

Readers on

mendeley: 117 Mendeley

So far, Altmetric has seen 1 policy document that references this research output.

Guselkumab for treating active psoriatic arthritis after inadequate response to DMARDs : Appraisal consultation committee papers

Cited by National Institute for Health and Care Excellence (NICE) on 30 Jun 2021

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.